A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of zinc-dependent extracellular enzymes that play a crucial role in a myriad of biological processes. These enzymes are active participants in the cleavage, restructuring, and maintenance of the extracellular matrix (ECM), which is a vital component of tissues and organs. Members of the ADAMTS family are involved in the proteolytic processing of various substrates within the ECM. Its signaling mechanisms are embedded within a web of regulatory pathways that include cytokine networks, growth factors, and other enzymes. These pathways modulate ADAMTS expression levels and enzymatic activity, implicating it in ECM remodeling, cell migration, and the modulation of other cellular behaviors. Factors like epigenetic regulation, substrate availability, and endogenous further add layers of complexity to the regulation of ADAMTS activity.
ADAMTS activators are aimed at understanding molecules that can specifically or indirectly modulate the activity of ADAMTS family members. While several types of molecules are being investigated for their role in activating or facilitating ADAMTS function, these range from small organic compounds to larger biological molecules. Small molecules like HDAC and TGF-β have been researched for their impact on the epigenetic and transcriptional regulation of ADAMTS family members, respectively. Others like MMP can indirectly contribute by preserving the availability of substrates in the ECM for ADAMTS proteins. Activators may also interact with ADAMTS members through various mechanisms such as inhibition of opposing pathways or through complex signaling cascades.
VEJA TAMBÉM
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Os inibidores HDAC podem influenciar a regulação epigenética da expressão do gene ADAMTS-20. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Ao inibir o TGF-β, estes poderiam potencialmente aumentar a expressão de ADAMTS-20 se o TGF-β for um supressor. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Os inibidores da DNA metiltransferase podem afetar o estado de metilação do gene ADAMTS-20, aumentando potencialmente a sua expressão. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $33.00 $73.00 $265.00 $112.00 | 34 | |
Pode ativar a ADAMTS-20 reduzindo as condições de stress oxidativo que, de outro modo, a inibem. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Os inibidores do NF-κB poderiam potencialmente aumentar a regulação da ADAMTS-20 através da supressão da sinalização do NF-κB, se o NF-κB atuar como um supressor. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Os inibidores da via Wnt podem influenciar a ADAMTS-20 ao afetar a sinalização Wnt, que é conhecida por estar envolvida na remodelação da MEC. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Os inibidores da PKC podem influenciar várias vias de sinalização que podem ativar indiretamente a ADAMTS-20. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Os inibidores JAK/STAT podem afetar a sinalização de citocinas que influencia a expressão ou a atividade da ADAMTS-20. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $112.00 $163.00 $928.00 | 19 | |
Os inibidores da MEK podem afetar as vias da MAPK que influenciam a ADAMTS-20. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $63.00 $173.00 | 7 | |
Os estabilizadores HIF-1α poderiam potencialmente influenciar a ativação ou expressão da ADAMTS-20 relacionada com a hipoxia. | ||||||